361 related articles for article (PubMed ID: 16162401)
1. The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study.
Rémillard S; Pourcher E; Cohen H
Schizophr Res; 2005 Dec; 80(1):99-106. PubMed ID: 16162401
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
Rémillard S; Pourcher E; Cohen H
J Int Neuropsychol Soc; 2008 Jan; 14(1):110-8. PubMed ID: 18078537
[TBL] [Abstract][Full Text] [Related]
3. [Cognition, schizophrenia and the effect of antipsychotics].
Stip E
Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
Harvey PD; Rabinowitz J; Eerdekens M; Davidson M
Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
[TBL] [Abstract][Full Text] [Related]
5. Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients.
Lee SM; Chou YH; Li MH; Wan FJ; Yen MH
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1101-7. PubMed ID: 17475386
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
Crespo-Facorro B; Rodríguez-Sánchez JM; Pérez-Iglesias R; Mata I; Ayesa R; Ramirez-Bonilla M; Martínez-Garcia O; Vázquez-Barquero JL
J Clin Psychiatry; 2009 Apr; 70(5):717-29. PubMed ID: 19389335
[TBL] [Abstract][Full Text] [Related]
7. The influence of switching from haloperidol decanoate depot to risperidone long-acting injection on the clinical symptoms and cognitive function in schizophrenia.
Suzuki H; Gen K
Hum Psychopharmacol; 2012 Sep; 27(5):470-5. PubMed ID: 23001955
[TBL] [Abstract][Full Text] [Related]
8. Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.
Roiz-Santiáñez R; Tordesillas-Gutiérrez D; Ortíz-García de la Foz V; Ayesa-Arriola R; Gutiérrez A; Tabarés-Seisdedos R; Vázquez-Barquero JL; Crespo-Facorro B
Schizophr Res; 2012 Oct; 141(1):22-8. PubMed ID: 22884754
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
10. Long-term skill proceduralization in schizophrenia.
Rémillard S; Pourcher E; Cohen H
J Int Neuropsychol Soc; 2010 Jan; 16(1):148-56. PubMed ID: 19900349
[TBL] [Abstract][Full Text] [Related]
11. Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol.
Sergi MJ; Green MF; Widmark C; Reist C; Erhart S; Braff DL; Kee KS; Marder SR; Mintz J
Am J Psychiatry; 2007 Oct; 164(10):1585-92. PubMed ID: 17898351
[TBL] [Abstract][Full Text] [Related]
12. Future employability, a new approach to cost-effectiveness analysis of antipsychotic therapy.
Ganguly R; Miller LS; Martin BC
Schizophr Res; 2003 Sep; 63(1-2):111-9. PubMed ID: 12892865
[TBL] [Abstract][Full Text] [Related]
13. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
[TBL] [Abstract][Full Text] [Related]
14. The effect of risperidone on cognitive functioning in a sample of Asian patients with schizophrenia in Singapore.
Chua L; Chong SA; Pang E; Ng VP; Chan YH
Singapore Med J; 2001 Jun; 42(6):243-6. PubMed ID: 11547959
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder.
Harvey PD; Napolitano JA; Mao L; Gharabawi G
Int J Geriatr Psychiatry; 2003 Sep; 18(9):820-9. PubMed ID: 12949850
[TBL] [Abstract][Full Text] [Related]
16. Correlates of cognitive deficits in first episode schizophrenia.
Heydebrand G; Weiser M; Rabinowitz J; Hoff AL; DeLisi LE; Csernansky JG
Schizophr Res; 2004 May; 68(1):1-9. PubMed ID: 15037334
[TBL] [Abstract][Full Text] [Related]
17. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.
Purdon SE; Jones BD; Stip E; Labelle A; Addington D; David SR; Breier A; Tollefson GD
Arch Gen Psychiatry; 2000 Mar; 57(3):249-58. PubMed ID: 10711911
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidol.
Addington J; Addington D
Can J Psychiatry; 1997 Nov; 42(9):983. PubMed ID: 9429073
[No Abstract] [Full Text] [Related]
20. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.
Purdon SE; Malla A; Labelle A; Lit W
J Psychiatry Neurosci; 2001 Mar; 26(2):137-49. PubMed ID: 11291531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]